The TROP2 paradox: enhancing precision in immunotherapy for advanced non-small cell lung cancer patients-a commentary

被引：0
|
作者：
Khan, Saqib Raza [1 ,2 ]
Verma, Saurav [1 ,2 ]
Breadner, Daniel [1 ,2 ]
Raphael, Jacques [1 ,2 ,3 ]
机构：
[1] Western Univ, Schulich Sch Med & Dent, Dept Oncol, Div Med Oncol, London, ON, Canada
[2] London Hlth Sci Ctr, Verspeeten Family Canc Ctr, London, ON, Canada
[3] Lawson Hlth Res Inst, London, ON, Canada
来源：
TRANSLATIONAL CANCER RESEARCH | 2025年 / 14卷 / 02期
关键词：
Lung cancer; immunotherapy; biomarker; resistance; TROP2; PLUS PEMBROLIZUMAB PEMBRO; DATOPOTAMAB DERUXTECAN; SACITUZUMAB GOVITECAN; OPEN-LABEL; ATEZOLIZUMAB; CHEMOTHERAPY; MULTICENTER; DOCETAXEL; COHORT; NSCLC;
D O I：
10.21037/tcr-24-1633
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：660 / 666
页数：7
相关论文
共 50 条
  • [21] Role of immunotherapy in locally advanced non-small cell lung cancer
    Levy, A.
    Doyen, J.
    Botticella, A.
    Bourdais, R.
    Achkar, S.
    Giraud, P.
    Du, C.
    Naltet, C.
    Lavaud, P.
    Besse, B.
    Pradere, P.
    Mercier, O.
    Caramella, C.
    Planchard, D.
    Deutsch, E.
    Le Pechoux, C.
    CANCER RADIOTHERAPIE, 2020, 24 (01): : 67 - 72
  • [22] Predicting response to immunotherapy in advanced non-small cell lung cancer
    Rebordao Pires, M.
    Amorim Costa, C.
    Cunha Pereira, T.
    Monteiro, J. C.
    Domingues, I.
    Caetano, A. C.
    Meira Garcia, A. R.
    Jesus, E.
    Sousa, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S768 - S768
  • [23] Immunotherapy in treatment naive advanced non-small cell lung cancer
    Ernani, Vinicius
    Ganti, Apar Kishor
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S412 - S421
  • [24] Neoadjuvant Immunotherapy for Patients with non-small cell Lung Cancer
    Luecke, E.
    Ganzert, C.
    Waesche, A.
    Walles, T.
    Schreiber, J.
    PNEUMOLOGIE, 2020, 74 : S74 - S75
  • [25] Continuous immunotherapy beyond disease progression in patients with advanced non-small cell and small cell lung cancer
    Cheng, Jing
    Kang, Wenwen
    Chen, Yueying
    Pan, Luyun
    Han, Hedong
    Lv, Tangfeng
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (04)
  • [26] Immunotherapy in patients with non-small cell lung cancer with ECOG PS 2
    Mojsak, Damian
    Kuklinska, Beata
    Deczynski, Michal
    Mroz, Robert Marek
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2021, 25 (01): : 53 - 56
  • [27] Immunotherapy for Non-Small Cell Lung Cancer
    Yoon, Sung Ho
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2014, 77 (03) : 111 - 115
  • [28] Immunotherapy for non-small cell lung cancer
    Vafadar, Sam
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 37 - 42
  • [29] Immunotherapy in non-small cell lung cancer
    Peters, Geoffrey
    John, Thomas
    CANCER FORUM, 2018, 42 (01) : 24 - 28
  • [30] Immunotherapy for non-small cell lung cancer
    Kagamu, Hiroshi
    RESPIRATORY INVESTIGATION, 2024, 62 (02) : 307 - 312
12345